FDA Inspection 1115203 — Far East Summit LLC

Far East Summit LLC — FEI 3008018326

The FDA completed an inspection of Far East Summit LLC on Jan 15, 2020 in Dexter, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 15, 2020
Fiscal Year
2020
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Dexter, OR (United States)

Citations

IDCFRDescription
1553221 CFR 111.255(b)Batch record - complete
1583221 CFR 111.70(c)(1)In-process identity, purity, strength, composition
1592721 CFR 111.103Written procedures - quality control operations

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.